评估提格环素治疗患者临床失败的危险因素
Chun-Fu Huang1, Jia-Ling Yang2, Yu-Chung Chuang2
1Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
Infection and drug resistance
|December 9, 2024
概括
提格环素的使用与患有多种并发病,血液感染和高皮特细菌性血症评分的患者的临床失败率较高有关. 临床医生应考虑替代方案,并密切监测患者的不良结果.
科学领域:
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
- 公共卫生 公共卫生
背景情况:
- 尽管有记录的较高的死亡风险,但tigecycline被广泛用于各种感染.
- 在现实环境中对tigecycline临床失败的风险因素仍未得到充分研究.
研究的目的:
- 为了确定与tigecycline治疗的患者临床失败相关的风险因素.
- 为了告知临床决策有关tigecycline在复杂感染中的使用.
主要方法:
- 一个前性队列 (2019-2021) 的tigecycline治疗患者的回顾性分析.
- 临床失败是指死亡率,持续的症状或需要进一步的抗菌药物治疗.
- 多变量后勤回归分析以确定临床失败的预测因素.
主要成果:
- 较高的查尔森并发症指数,皮特细菌病评分和血液感染是临床失败的重要预测因素.
- 同时使用Pseudomonas aeruginosa活性基诺和卡巴胺增加了临床失败的风险.
- 肺炎是最常见的感染部位 (46.3%),其次是血液感染 (25.3%).
结论:
- 多种并发病,血液感染和高的皮特细菌性血症得分与提格环素临床失败的增加有关.
- 考虑替代抗生素的患者与已识别的危险因素.
- 在施用tigecycline时,警的患者监测至关重要,以减轻潜在的临床失败.
相关概念视频
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
00:57Antibiotic Selection
52.3K
Overview
52.3K